{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:01:10Z","timestamp":1791403270917,"version":"4.3.3"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pharep.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T15:33:19Z","timestamp":1470411199000},"page":"1254-1265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Benzimidazole-core as an antimycobacterial agent"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-8379","authenticated-orcid":false,"given":"Rangappa S.","family":"Keri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethana Kolambae","family":"Rajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddappa A.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhari Mallanna","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.08.002_bib0005","unstructured":"Tuberculosis (online), http\/\/www.wrongdiagnosis.com\/t\/tuberclosis, 26TH 2011."},{"key":"10.1016\/j.pharep.2016.08.002_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.18773\/austprescr.2010.005","article-title":"Testing for tuberculosis","volume":"33","author":"Konstantinos","year":"2010","journal-title":"Aust Prescr"},{"key":"10.1016\/j.pharep.2016.08.002_bib0015","first-page":"44","article-title":"Tuberculosis: a comprehensive clinical reference","author":"Grange","year":"2009"},{"key":"10.1016\/j.pharep.2016.08.002_bib0020","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"World health organization (WHO). Global surveillance and monitoring project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2016.08.002_bib0025","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/j.ijid.2009.12.003","article-title":"Robert Koch and the \u2018golden age\u2019 of bacteriology","volume":"14","author":"Blevins","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.pharep.2016.08.002_bib0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/med.20190","article-title":"Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis","volume":"30","author":"Umesiri","year":"2010","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0035","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1099\/jmm.0.019372-0","article-title":"Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France","volume":"59","author":"Panteix","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.pharep.2016.08.002_bib0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1165\/rcmb.2007-0413OC","article-title":"Mycobacterium abscessus and M. avium trigger toll-like receptor 2 and distinct cytokine response in human cells","volume":"39","author":"Sampaio","year":"2008","journal-title":"Am J Resp Cell Mol Biol"},{"key":"10.1016\/j.pharep.2016.08.002_bib0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1472-9792(02)00064-1","article-title":"A short history of Robert Koch\u2019s fight against tuberculosis: those who do notremember the past are condemned to repeat it","volume":"83","author":"Kaufmann","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.pharep.2016.08.002_bib0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharep.2016.08.002_bib0055","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1021\/jm200305q","article-title":"Current status and research strategies in tuberculosis drug development","volume":"54","author":"Dover","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.257.5073.1055","article-title":"Tuberculosis: commentary on a reemergent killer","volume":"257","author":"Bloom","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharep.2016.08.002_bib0065","first-page":"783","article-title":"Recent progress in mycobacteriology","volume":"82","author":"Okada","year":"2007","journal-title":"Kekkaku"},{"key":"10.1016\/j.pharep.2016.08.002_bib0070","unstructured":"World Health Organization Report on TB epidemic, Global TB Programme, World Health Oraganization Geneva, (1997)."},{"key":"10.1016\/j.pharep.2016.08.002_bib0075","unstructured":"World health organisation, Tuberculosis (2007); Fact Sheet No.104."},{"key":"10.1016\/j.pharep.2016.08.002_bib0080","unstructured":"World health organization. Global tuberculosis report. (2013)."},{"key":"10.1016\/j.pharep.2016.08.002_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2008.08.002","article-title":"Tuberculosis in Africa: learning from pathogenesis for biomarker identification","volume":"4","author":"Kaufmann","year":"2008","journal-title":"Cell Host Microb"},{"key":"10.1016\/j.pharep.2016.08.002_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nm0307-309","article-title":"Tuberculosis, a neglected opportunity","volume":"13","author":"Harper","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharep.2016.08.002_bib0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/156802607780059736","article-title":"New tuberculosis drugs in development","volume":"7","author":"Laughon","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0100","first-page":"387","article-title":"Redefining MDR-TB transmission \u2018hotspots\u2019","volume":"4","author":"Becerra","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.pharep.2016.08.002_bib0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/med.20190","article-title":"Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis","volume":"30","author":"Umesiri","year":"2010","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1098-1128(200101)21:1<61::AID-MED2>3.0.CO;2-F","article-title":"Benzo[c]phenanthridine bases and their antituberculosis activity","volume":"21","author":"Ishikawa","year":"2001","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/med.20017","article-title":"Fighting tuberculosis: an old disease with newchallenges","volume":"25","author":"Tripathi","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/med.20170","article-title":"Antitubercular potential of plants: a brief account of some important molecules","volume":"30","author":"Negi","year":"2010","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0125","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J Antimicrob Chemoth"},{"key":"10.1016\/j.pharep.2016.08.002_bib0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/med.21262","article-title":"Antituberculosis drug research: a critical overview","volume":"33","author":"Beena","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharep.2016.08.002_bib0135","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cber.18720050295","article-title":"Reduction-products of nitracetamide compounds","volume":"5","author":"Hobrecker","year":"1872","journal-title":"Deut Chem Ges Ber"},{"key":"10.1016\/j.pharep.2016.08.002_bib0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cber.187500801209","article-title":"Derivatives of diamines","volume":"8","author":"Ladenberg","year":"1875","journal-title":"Deut Chem Ges Ber"},{"key":"10.1016\/j.pharep.2016.08.002_bib0145","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cber.187801101221","article-title":"Derivatives of phenylenediamines","volume":"11","author":"Wundt","year":"1878","journal-title":"Deut Chem Ges Ber"},{"key":"10.1016\/j.pharep.2016.08.002_bib0150","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0960-894X(02)00346-3","article-title":"Synthesis and antiparasitic activity of 1H-benzimidazole derivatives","volume":"12","author":"Valdez","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0155","first-page":"447","article-title":"A systematic review of benzimidazole derivatives as an antiulcer agent","volume":"1","author":"Patil","year":"2008","journal-title":"Rasayan J Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0160","first-page":"63","article-title":"Benzimidazoles in a wormy world","volume":"5","author":"Dubey","year":"2010","journal-title":"Online Vet J"},{"key":"10.1016\/j.pharep.2016.08.002_bib0165","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/j.bmcl.2004.04.097","article-title":"Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa","volume":"14","author":"Mederski","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0170","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0040-4020(00)01158-3","article-title":"A short synthesis of phenanthro[2,3-d]imidazoles from dehydroabietic acid: application of the methodology as a convenient route to benzimidazoles","volume":"57","author":"Fonseca","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.pharep.2016.08.002_bib0175","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1016\/j.tetlet.2005.08.143","article-title":"Microwave-assisted synthesis of 1-aryl-1H-indazoles via one-pot two-step Cu-catalyzed intramolecular N-arylation of arylhydrazones","volume":"46","author":"Pabba","year":"2005","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0180","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/jm00164a054","article-title":"Potential antitumor agents 59 structure-activity relationships for 2-phenylbenzimidazole-4-carboxamidesa, new class of minimal DNA-Intercalating agents which may not act via topoisomerase II","volume":"33","author":"Denny","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0185","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.bmcl.2008.05.009","article-title":"Design, synthesis and in vitro antiprotozoal activity of benzimidazole pentamidine hybrids","volume":"18","author":"Gomez","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0190","first-page":"1235","article-title":"Ribonucleic acid synthesis and influenza virus multiplication","volume":"126","author":"Tamm","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.pharep.2016.08.002_bib0195","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1002\/anie.200460326","article-title":"Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics strategy","volume":"43","author":"LaPlante","year":"2004","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.pharep.2016.08.002_bib0200","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/jm960547h","article-title":"Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazolebioisosteres","volume":"39","author":"Kohara","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0205","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1021\/jm9706630","article-title":"Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]-benzimidazoles as selective neuropeptide Y Y1 receptor antagonists","volume":"41","author":"Zarrinmayeh","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/jm950412w","article-title":"Substituted 2,5\u2032-bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity","volume":"39","author":"Kim","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0215","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1021\/jm970096g","article-title":"Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-aryl-substituted benzimidazoles","volume":"40","author":"Roth","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0220","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.bmcl.2008.02.071","article-title":"Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors","volume":"18","author":"Wallace","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0225","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/ja030196d","article-title":"Ruffling-Induced chirality: synthesis, metalation, and optical resolution of highly nonplanar, cyclic, benzimidazole-based ligands","volume":"126","author":"Fekner","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharep.2016.08.002_bib0230","unstructured":"A Mahiuddin, DC Black, N Kumar, Synthesis, reactivity and biological activity of benzimidazoles: Top. Heterocycl Chem. Springer-Verlag Berlin Heidelberg, 9, (2007), 87\u2013118"},{"key":"10.1016\/j.pharep.2016.08.002_bib0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1389557053544047","article-title":"Imidazole and benzimidazole derivatives as chemotherapeutic agents","volume":"5","author":"Boiani","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00044-010-9533-9","article-title":"A medicinally important heterocyclic moiety","volume":"21","author":"Narasimhan","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.pharep.2016.08.002_bib0245","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","article-title":"The therapeutic journey of benzimidazoles. A review","volume":"20","author":"Bansal","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1574885511308010001","article-title":"Benzimidazole derivatives as potential chemotherapeutic agents","volume":"8","author":"Rashedy","year":"2013","journal-title":"Curr Drug Ther"},{"key":"10.1016\/j.pharep.2016.08.002_bib0255","series-title":"Synthetic studies on novel coumarin and benzimidazole derivatives: an pharmacological approach PhD Thesis","author":"Keri","year":"2009"},{"key":"10.1016\/j.pharep.2016.08.002_bib0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0265","first-page":"26","article-title":"Heterocyclic chemistry of benzimidazoles and potential activities of derivatives","volume":"1","author":"Ingle","year":"2011","journal-title":"Int J Drug Res Tech"},{"key":"10.1016\/j.pharep.2016.08.002_bib0270","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jo01066a039","article-title":"Acidity constants of some arylimidazoles and their cations","volume":"26","author":"Walba","year":"1961","journal-title":"J Org Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0275","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejmech.2014.01.039","article-title":"Benzimidazole-based compounds kill Mycobacterium tuberculosis","volume":"75","author":"Gong","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0280","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2014.06.004","article-title":"antibacterial and antitubercular activities of benzimidazole bearing substituted 2-pyridone motifs","volume":"82","author":"Desai","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0285","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ejmech.2013.06.025","article-title":"Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters","volume":"93","author":"Yoon","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0290","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejmech.2014.04.017","article-title":"Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives","volume":"79","author":"Kumar","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0295","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bmc.2011.01.050","article-title":"Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents","volume":"19","author":"Camacho","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0300","first-page":"926309","article-title":"Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives","volume":"2013","author":"Yoon","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.pharep.2016.08.002_bib0305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/jm1012006","article-title":"Novel trisubstituted benzimidazoles, targeting MtbFtsZ, as a new class of antitubercular agents","volume":"54","author":"Kumar","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0310","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.bmc.2014.03.035","article-title":"Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents","volume":"22","author":"Park","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0315","doi-asserted-by":"crossref","first-page":"9756","DOI":"10.1021\/jm401468w","article-title":"SAR studies on trisubstituted benzimidazoles as inhibitors of MtbFtsZ for the development of novel antitubercular agents","volume":"56","author":"Awasthi","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0320","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bmc.2011.11.020","article-title":"Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity","volume":"20","author":"Gobis","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2014.10.031","article-title":"Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues","volume":"7","author":"Gobis","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0330","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ml4002248","article-title":"Identification of 1-[4-benzyloxyphenyl)-but-3-enyl]-1H-azolesas new class of antitubercular and antimicrobial agents","volume":"4","author":"Anand","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0335","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cmdc.201000275","article-title":"Inhibitors of the salicylate synthase (MbtI) from mycobacterium tuberculosis discovered by high-throughput screening","volume":"5","author":"Vasan","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0340","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cmdc.201000490","article-title":"Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB","volume":"6","author":"Pieroni","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2012.03.033","article-title":"Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl)acetamides as antibacterial, antifungal and antituberculosis agents","volume":"53","author":"Patel","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0350","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/ml5001728","article-title":"Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing","volume":"5","author":"Hameed","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0355","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1016\/j.bmcl.2013.06.072","article-title":"Guru Row TN, Rishikesan R, et al: design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1Hbenzimidazoles as possible antimicrobial and antitubercular agents","volume":"23","author":"Ranjith","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0360","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00044-012-0322-5","article-title":"Microwave-assisted synthesis of pyrido[1,2-a]benzimidazole derivatives of b-aryloxyquinoline and their antimicrobialand antituberculosis activities","volume":"22","author":"Sangani","year":"2013","journal-title":"Med Chem Res"},{"key":"10.1016\/j.pharep.2016.08.002_bib0365","first-page":"644","article-title":"Design and synthesis of novel benzimidazole derivatives as anti-tuberculosis agents","volume":"49","author":"Hui-Ying","year":"2014","journal-title":"Acta Pharmaceut Sinica"},{"key":"10.1016\/j.pharep.2016.08.002_bib0370","first-page":"317","article-title":"Design and synthesis of some new imidazole and 1,2,4-triazole substituted fluorobenzimidazoles for antitubercular and antifungal activity","volume":"5","author":"Nandha","year":"2013","journal-title":"Der Pharma Chemica"},{"key":"10.1016\/j.pharep.2016.08.002_bib0375","first-page":"150","article-title":"Design, docking and synthesis of some 6-benzimidazoyl pyrans and screening of their anti tubercular activity","volume":"1","author":"Saleshier","year":"2011","journal-title":"Eur J Exp Bio"},{"key":"10.1016\/j.pharep.2016.08.002_bib0380","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.ejmech.2009.05.021","article-title":"Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles","volume":"44","author":"Shingalapur","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0385","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1016\/j.bmcl.2008.09.096","article-title":"Clubbed [1\u20133] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis","volume":"18","author":"Gill","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejmech.2004.10.004","article-title":"Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles","volume":"40","author":"Kazimierczuk","year":"2005","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0395","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-827X(02)01218-1","article-title":"New benzimidazole derivatives as antimycobacterial agents","volume":"57","author":"Klimesova","year":"2002","journal-title":"IL Farmaco"},{"key":"10.1016\/j.pharep.2016.08.002_bib0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2012.03.033","article-title":"Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl)acetamides as antibacterial, antifungal and antituberculosis agents","volume":"53","author":"Patel","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0405","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.ejmech.2008.12.001","article-title":"SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazolesas antimicrobial and antituberculosis agents","volume":"44","author":"Jadhav","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0410","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1016\/j.ejmech.2009.02.013","article-title":"Synthesis and antitubercular screening of imidazole derivatives","volume":"44","author":"Pandey","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0415","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1016\/j.bmcl.2008.10.045","article-title":"A facile synthesis, antibacterial, and antitubercular studies of some piperidin-4-one and tetrahydropyridine derivatives","volume":"18","author":"Aridoss","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0420","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10593-006-0135-x","article-title":"Synthesis and tuberculostatic activity of new benzimidazole derivatives","volume":"42","author":"Foks","year":"2006","journal-title":"Chem Heterocycl Comp"},{"key":"10.1016\/j.pharep.2016.08.002_bib0425","unstructured":"I Ojima, Preparation of benzimidazole derivatives for use in the treatment of Mycobacterium tuberculosis or Mycobacterium avium complex infections. WO 2013116823 A1; (2013)."},{"key":"10.1016\/j.pharep.2016.08.002_bib0430","unstructured":"I Ojima, S Lee, Benzimidazoles and pharmaceutical compositions there of PCT Int Appl. US8232410 B2; (2008)."},{"key":"10.1016\/j.pharep.2016.08.002_bib0435","first-page":"583","article-title":"Synthesis and biological evaluation of amino alcohol derivatives of 2-methylbenzimidazole as antitubercular and antibacterial agents","volume":"5","author":"Birajdara","year":"2013","journal-title":"J Chem Pharm Res"},{"key":"10.1016\/j.pharep.2016.08.002_bib0440","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bmcl.2009.10.026","article-title":"Babu Rao C. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones","volume":"20","author":"Ramalingam","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2016.08.002_bib0445","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/znb-2006-0120","article-title":"Synthesis and antimycobacterial and antiprotozoal activities of some novel nitrobenzylated heterocycles","volume":"61","author":"Gorska","year":"2006","journal-title":"Zeitschrift fuer Naturforschung B: Chem Sci"},{"key":"10.1016\/j.pharep.2016.08.002_bib0450","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/10426500601088721","article-title":"Dimethyl dithioimidocarbonates-mediated heterocyclizations: synthesis of imidazolidines and benzheterocycles as potent antitubercular agents Phosphorus","volume":"182","author":"Hegde","year":"2007","journal-title":"Sulfur Silicon"},{"key":"10.1016\/j.pharep.2016.08.002_bib0455","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2015.03.024","article-title":"Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives","volume":"95","author":"Ramprasad","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2016.08.002_bib0460","unstructured":"I Ojima, SY Lee, Preparation of benzimidazoles for treatment of Mycobacterium tuberculosis or Francisella tularensis infection. WO 2008130669; (2008)."}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:38Z","timestamp":1752611798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.08.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1734114016301049"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.08.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzimidazole-core as an antimycobacterial agent","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}